Publications by authors named "Shinichiro Tada"

Claim this Profile
A
A case of severe osteomalacia caused by Tubulointerstitial nephritis with Fanconi syndrome in asymptomotic primary biliary cirrhosis.
Shintaro Yamaguchi, Tatsuya Maruyama, Shu Wakino, Hirobumi Tokuyama, Akinori Hashiguchi, Shinichiro Tada, Tadashi Yoshida

BMC Nephrol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disadvantages of peginterferon and ribavirin treatment in older patients with chronic hepatitis C: an analysis using the propensity score.
Hirotoshi Ebinuma, Hidetsugu Saito, Shinichiro Tada, Nobuhiro Nakamoto, Tazuko Ohishi

Hepatol Int· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of effect of pegylated interferon alpha-2b plus ribavirin combination therapy in patients with chronic hepatitis C infection.
Tetsuro Takayama, Hirotoshi Ebinuma, Shinichiro Tada, Yoshiyuki Yamagishi, Kanji Wakabayashi

PLoS One· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel scoring system as a useful model to predict the outcome of patients with acute liver failure: Application to indication criteria for liver transplantation.
Takafumi Naiki, Nobuaki Nakayama, Satoshi Mochida, Makoto Oketani, Yasuhiro Takikawa, Shin-Ichiro Tada

Hepatol Res· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNMT1 and DNMT3b silencing sensitizes human hepatoma cells to TRAIL-mediated apoptosis via up-regulation of TRAIL-R2/DR5 and caspase-8.
Satoshi Kurita, Hajime Higuchi, Yoshimasa Saito, Nobuhiro Nakamoto, Hiromasa Takaishi, Shinichiro Tada

Cancer Sci· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
On-treatment predictions of success in peg-interferon/ribavirin treatment using a novel formula.
Hidetsugu Saito, Hirotoshi Ebinuma, Keisuke Ojiro, Kanji Wakabayashi, Mika Inoue, Shinichiro Tada

World J Gastroenterol· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Operative management of skull base malignant tumors arising from the nasal cavity and paranasal sinus: recent strategies used in 25 cases.
Hiroyuki Jimbo, Shinetsu Kamata, Kouki Miura, Shunji Asamoto, Shinichiro Tada

Neurol Med Chir (Tokyo)· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatocellular carcinoma in Keio affiliated hospitals--diagnosis, treatment, and prognosis of this disease.
Hidetsugu Saito, Tetsuya Masuda, Shinichiro Tada, Hirotoshi Ebinuma, Yoshiyuki Yamagishi

Keio J Med· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new prognostic formula for adult acute liver failure using computer tomography-derived hepatic volumetric analysis.
Yoshiyuki Yamagishi, Hidetsugu Saito, Hirotoshi Ebinuma, Masahiro Kikuchi, Keisuke Ojiro, Shinichiro Tada

J Gastroenterol· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of hepatitis C virus with peg-interferon and ribavirin combination therapy significantly affects lipid metabolism.
Shinichiro Tada, Hidetsugu Saito, Hirotoshi Ebinuma, Keisuke Ojiro, Yoshiyuki Yamagishi

Hepatol Res· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reactivation of hepatitis B in a patient with Crohn's disease treated using infliximab.
Keisuke Ojiro, Makoto Naganuma, Hirotoshi Ebinuma, Hiroyoshi Kunimoto, Shinichiro Tada

J Gastroenterol· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Possible molecular mechanism of the relationship between NS5B polymorphisms and early clearance of hepatitis C virus during interferon plus ribavirin treatment.
Mitsuyasu Nakamura, Hidetsugu Saito, Masanori Ikeda, Shinichiro Tada, Naoki Kumagai, Kunitada Shimotohno

J Med Virol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rho/Rho kinase is a key enzyme system involved in the angiotensin II signaling pathway of liver fibrosis and steatosis.
Kumi Kitamura, Shinichiro Tada, Nobuhiro Nakamoto, Kyoko Toda, Hitomi Horikawa

J Gastroenterol Hepatol· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of erythrocytes as a reservoir for ribavirin and relationship with adverse reactions in the early phase of interferon combination therapy for chronic hepatitis C virus infections.
Hidetsugu Saito, Shinichiro Tada, Hirotoshi Ebinuma, Hiromasa Ishii, Kazuo Kashiwazaki

J Clin Microbiol· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of natural BALL-1 interferon-alpha treatment for patients with chronic hepatitis C and a possible enhancing effect of a twice-daily starting regimen with interferon-beta.
Hirotoshi Ebinuma, Hidetsugu Saito, Shinichiro Tada, Nobuhiro Nakamoto, Satoshi Kurita

Hepatogastroenterology· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclooxygenase-2 inhibitor and interferon-beta synergistically induce apoptosis in human hepatoma cells in vitro and in vivo.
Nobuhiro Nakamoto, Hajime Higuchi, Hideaki Kanamori, Satoshi Kurita, Shinichiro Tada

Int J Oncol· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction therapy with twice-daily interferon-beta does not improve the therapeutic efficacy of consensus interferon monotherapy for chronic hepatitis C.
Hidetsugu Saito, Shinichiro Tada, Hirotoshi Ebinuma, Hiromasa Ishii, Kazuo Kashiwazaki

Keio J Med· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful management of liver injury caused by imatinib mesylate in a patient with previously untreated chronic myelogenous leukemia in the chronic phase.
Rie Yamazaki, Shinichiro Okamoto, Chien-Kang Chen, Shinichiro Tada, Hidetane Saito

Leuk Lymphoma· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic benefit of sulfasalazine for patients with primary sclerosing cholangitis.
Shinichiro Tada, Hirotoshi Ebinuma, Hidetsugu Saito, Toshifumi Hibi

J Gastroenterol· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Value of computed tomography-derived estimated liver volume/standard liver volume ratio for predicting the prognosis of adult fulminant hepatic failure in Japan.
Yoshiyuki Yamagishi, Hidetsugu Saito, Shinichiro Tada, Yoshinori Horie, Shinzo Kato

J Gastroenterol Hepatol· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of long-term interferon therapy for refractory chronic hepatitis c: preventive effect on hepatocarcinogenesis.
Yoshimasa Saito, Hidetsugu Saito, Shinichiro Tada, Nobuhiro Nakamoto, Hitomi Horikawa

Hepatogastroenterology· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contribution of Irf-1 promoter polymorphisms to the Th1-type cell response and interferon-beta monotherapy for chronic hepatitis C.
Hidetsugu Saito, Shinichiro Tada, Nobuhiro Nakamoto, Kumi Kitamura, Hiromi Horikawa

Hepatol Res· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Primary sclerosing cholangitis].
Shinichiro Tada, Hidetsugu Saito, Toshifumi Hibi

Nihon Rinsho· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene expression associated with the decrease in malignant phenotype of human liver cancer cells following stimulation with a histone deacetylase inhibitor.
Kanji Wakabayashi, Hidetsugu Saito, Fumihiko Kaneko, Nobuhiro Nakamoto, Shinichiro Tada

Int J Oncol· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of non-invasive elastometry on staging of hepatic fibrosis.
Hidetsugu Saito, Shinichiro Tada, Nobuhiro Nakamoto, Kumi Kitamura, Hitomi Horikawa

Hepatol Res· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis